Concerns about heparin therapy for hypertriglyceridemia.
Whayne
Thomas F
TF
D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood*; D016883:Diabetic Ketoacidosis / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D011345:Fenofibrate / Q000008:administration & dosage; D006207:Half-Life; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D019283:Pancreatitis, Acute Necrotizing / Q000517:prevention & control; D011758:Pyrroles / Q000008:administration & dosage; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D015525:Fatty Acids, Omega-3; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D007328:Insulin; D011758:Pyrroles; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol; D000069059:Atorvastatin; D011345:Fenofibrate